CUV Update - Notification of buy-back - CUV 10/05/24 download Created with Sketch. 15.7KB Share CUV Update - Notification of buy-back - CUV 09/05/24 download Created with Sketch. 15.69KB Share CUV Update - Notification of buy-back - CUV 06/05/24 download Created with Sketch. 15.7KB Share CUV Update - Notification of buy-back - CUV 03/05/24 download Created with Sketch. 15.7KB Share CUV Syd Capital Markets Briefing Presentation 01/05/24 download Created with Sketch. 4.01MB Share CUV SCENESSE European Orphan Drug Designation for XP 29/04/24 download Created with Sketch. 88.75KB Share CUV Notification of cessation of securities - CUV 29/04/24 download Created with Sketch. 12.86KB Share CUV Update - Notification of buy-back - CUV 29/04/24 download Created with Sketch. 15.7KB Share CUV Ceasing to be a substantial holder 26/04/24 download Created with Sketch. 856.04KB Share CUV CLINUVEL expands global leadership team 22/04/24 download Created with Sketch. 76.98KB Share CUV Change to executive management 15/04/24 download Created with Sketch. 63.29KB Share CUV Update - Notification of buy-back - CUV 12/04/24 download Created with Sketch. 15.7KB Share CUV Update - Notification of buy-back - CUV 10/04/24 download Created with Sketch. 15.69KB Share CUV Update - Notification of buy-back - CUV 09/04/24 download Created with Sketch. 15.68KB Share CUV Becoming a substantial holder 09/04/24 download Created with Sketch. 1.22MB Share CUV Notification of cessation of securities - CUV 04/04/24 download Created with Sketch. 12.69KB Share CUV CLINUVEL Newsletter II - March 2024 20/03/24 download Created with Sketch. 257.3KB Share CUV Update - Notification of buy-back - CUV 18/03/24 download Created with Sketch. 13.65KB Share CUV Notification of buy-back - CUV 14/03/24 download Created with Sketch. 13.06KB Share CUV CLINUVEL initiates on market share buy-back program 14/03/24 PRICE SENSITIVE download Created with Sketch. 89.87KB Share CUV New case of SCENESSE efficacy in vitiligo presented at AAD 11/03/24 PRICE SENSITIVE download Created with Sketch. 362.39KB Share CUV SCENESSE Presented at American Academy of Dermatology 08/03/24 download Created with Sketch. 74.91KB Share CUV Ceasing to be a substantial holder 05/03/24 download Created with Sketch. 1.12MB Share CUV SCENESSE provides photoprotection in variegate porphyria 04/03/24 PRICE SENSITIVE download Created with Sketch. 195.58KB Share CUV Becoming a substantial holder 28/02/24 download Created with Sketch. 1.69MB Share CUV Final Director's Interest Notice 27/02/24 download Created with Sketch. 188.5KB Share CUV Half Year Results Webinar Recording 23/02/24 download Created with Sketch. 58.64KB Share CUV CLINUVEL Delivers Increased Revenues, Solid Earnings 22/02/24 download Created with Sketch. 107.14KB Share CUV CUV Appendix 4D Half Year Report 22/02/24 PRICE SENSITIVE download Created with Sketch. 570.89KB Share CUV Director Resignation 21/02/24 download Created with Sketch. 67.94KB Share CUV CEO Letter to Shareholders 16/02/24 download Created with Sketch. 103.23KB Share CUV Half Year Results Investor Webinar 16/02/24 download Created with Sketch. 59.78KB Share CUV Change in substantial holding 31/01/24 download Created with Sketch. 1.58MB Share CUV CLINUVEL Newsletter 1 - January 2024 16/01/24 download Created with Sketch. 256.64KB Share CUV Chair Elect Letter 14/12/23 download Created with Sketch. 106.04KB Share CUV Change to Registered Office 07/12/23 download Created with Sketch. 129.35KB Share CUV Notification of cessation of securities - CUV 27/11/23 download Created with Sketch. 21.49KB Share CUV Change of Director's Interest Notice 27/11/23 download Created with Sketch. 526.02KB Share CUV Application for quotation of securities - CUV 27/11/23 download Created with Sketch. 25.55KB Share CUV CLINUVEL Newsletter V - November 2023 24/11/23 download Created with Sketch. 481.47KB Share CUV Sydney Vitiligo Presentation 10/11/23 download Created with Sketch. 874.94KB Share CUV Final Director's Interest Notice 02/11/23 download Created with Sketch. 190.98KB Share CUV CLINUVEL Appoints New Chair 31/10/23 download Created with Sketch. 135.75KB Share CUV Results of Meeting 31/10/23 download Created with Sketch. 276.04KB Share CUV CEO Presentation AGM 31/10/23 download Created with Sketch. 1.94MB Share CUV Chair's Address 31/10/23 download Created with Sketch. 160.97KB Share CUV CLINUVEL starts global Phase III vitiligo study 18/10/23 download Created with Sketch. 233.67KB Share CUV CLINUVEL Newsletter IV - October 2023 06/10/23 download Created with Sketch. 245.17KB Share CUV Board Changes after AGM 29/09/23 download Created with Sketch. 141.26KB Share CUV Notice of Annual General Meeting/Proxy Form 29/09/23 download Created with Sketch. 577.45KB Share CUV Change of Director's Interest Notice 20/09/23 download Created with Sketch. 321.36KB Share CUV CEO Letter to Shareholders 19/09/23 download Created with Sketch. 192.64KB Share CUV CLINUVEL Confirms AGM Date 13/09/23 download Created with Sketch. 117.29KB Share CUV CLINUVEL Vitiligo Expert Panel 12/09/23 download Created with Sketch. 217.38KB Share CUV SCENESSE in Adolescent EPP Study 05/09/23 download Created with Sketch. 228.91KB Share CUV CLINUVEL Investor Webinar Transcript 30/08/23 download Created with Sketch. 895.6KB Share CUV Appendix 4G and Corporate Governance Statement 29/08/23 download Created with Sketch. 579.18KB Share CUV CLINUVEL delivering increases in annual revenue, profit 29/08/23 download Created with Sketch. 271.69KB Share CUV Dividend/Distribution - CUV 29/08/23 download Created with Sketch. 22.38KB Share CUV Appendix 4E and Annual Report to Shareholders 2023 29/08/23 PRICE SENSITIVE download Created with Sketch. 12.68MB Share CUV Annual Results Investor Webinar - time 28/08/23 download Created with Sketch. 131.05KB Share CUV Technical Note - CUV151 results DNA Damage 15/08/23 download Created with Sketch. 365.52KB Share CUV afamelanotide reduces DNA damage in healthy population 15/08/23 download Created with Sketch. 203.48KB Share CUV SCENESSE applied under 5 year US Veterans Affairs contract 26/07/23 download Created with Sketch. 140.08KB Share CUV CLINUVEL secures IP for melanocortins to treat CNS disorders 14/07/23 download Created with Sketch. 641.45KB Share CUV Notification regarding unquoted securities - CUV 30/06/23 download Created with Sketch. 25.38KB Share CUV Two Grounds of Appeal Upheld by NICE Panel 30/06/23 download Created with Sketch. 112.15KB Share CUV Notification of cessation of securities - CUV 29/06/23 download Created with Sketch. 21.48KB Share CUV Presentation - Melbourne Twilight Briefing 29/06/23 download Created with Sketch. 1.08MB Share CUV Change of Director's Interest Notice 28/06/23 download Created with Sketch. 313.22KB Share CUV CLINUVEL Newsletter III - June 2023 26/06/23 download Created with Sketch. 303.33KB Share CUV Strategic Update VI 01/06/23 download Created with Sketch. 1.84MB Share CUV PRENUMBRA administered to moderate & severe stroke patients 09/05/23 download Created with Sketch. 165.07KB Share CUV Expansion of global porphyria programs 01/05/23 download Created with Sketch. 136.22KB Share CUV CLINUVEL Newsletter II - April 2023 05/04/23 download Created with Sketch. 425.3KB Share CUV Investor Presentation - NYC Nasdaq Event 30/03/23 download Created with Sketch. 4.12MB Share CUV Technical Note - CUV803 Study and AIS 20/03/23 download Created with Sketch. 444.01KB Share CUV First stroke patient treated with PRENUMBRA Instant 20/03/23 download Created with Sketch. 271.53KB Share CUV DNA Repair data presented at AAD Meeting 17/03/23 download Created with Sketch. 119.77KB Share CUV Statement on Silicon Valley Bank 13/03/23 download Created with Sketch. 89.95KB Share CUV Proposed issue of securities - CUV 10/03/23 download Created with Sketch. 24.54KB Share CUV Commercial Update SCENESSE 09/03/23 download Created with Sketch. 127.84KB Share CUV Relief from Quarterly Reporting 02/03/23 download Created with Sketch. 82.33KB Share CUV CLINUVEL launches first dermatocosmetic product 01/03/23 download Created with Sketch. 254.92KB Share CUV Proposed issue of securities - CUV 28/02/23 download Created with Sketch. 24.53KB Share CUV Global SCENESSE demand drives increased revenues, earnings 24/02/23 download Created with Sketch. 165.94KB Share CUV CUV Appendix 4D Half Year Report 24/02/23 PRICE SENSITIVE download Created with Sketch. 874.85KB Share CUV PRENUMBRA formulation completed for clinical trial use 15/02/23 download Created with Sketch. 257.84KB Share CUV Chair's Letter 09/02/23 download Created with Sketch. 215.25KB Share CUV Technical note - CUV151 results 02/02/23 download Created with Sketch. 370.66KB Share CUV Afamelanotide reduces UV skin damage in a healthy population 02/02/23 download Created with Sketch. 168.07KB Share CUV Quarterly Activities/Appendix 4C Cash Flow Report 31/01/23 PRICE SENSITIVE download Created with Sketch. 229.38KB Share CUV NEURACTHEL manufacturing processes advance 23/01/23 download Created with Sketch. 359.1KB Share CUV Technical Note - Xeroderma Pigmentosum 16/01/23 download Created with Sketch. 609.83KB Share CUV afamelanotide Reduces DNA Photodamage in XP 16/01/23 download Created with Sketch. 333.77KB Share CUV CLINUVEL Newsletter I - January 2023 10/01/23 download Created with Sketch. 510.39KB Share CUV CLINUVEL Newsletter VI - December 2022 23/12/22 download Created with Sketch. 246.06KB Share CUV Notification of cessation of securities - CUV 21/12/22 download Created with Sketch. 21.48KB Share CUV Presentation - Jefferies London Healthcare Conference 17/11/22 download Created with Sketch. 3.31MB Share CUV CLINUVEL Newsletter V - November 2022 09/11/22 download Created with Sketch. 546.94KB Share
